Healthcare provider profile · identity verified

Elizabeth A Robb

Family Practice · ALBANY, OR · NPI 1184158479

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	408	128
Levothyroxine Sodium	Levothyroxine Sodium	346	94
Lisinopril	Lisinopril	270	85
Omeprazole	Omeprazole	240	74
Amlodipine Besylate	Amlodipine Besylate	233	73
Gabapentin	Gabapentin	225	62
Losartan Potassium	Losartan Potassium	196	69
Metoprolol Succinate	Metoprolol Succinate	155	51
Trazodone Hcl	Trazodone Hcl	149	44
Albuterol Sulfate Hfa	Albuterol Sulfate	134	52
Metformin Hcl	Metformin Hcl	124	38
Pantoprazole Sodium	Pantoprazole Sodium	112	34
Rosuvastatin Calcium	Rosuvastatin Calcium	108	35
Furosemide	Furosemide	102	32
Sertraline Hcl	Sertraline Hcl	101	24
Eliquis	Apixaban	94	25
Metformin Hcl Er	Metformin Hcl	94	34
Simvastatin	Simvastatin	84	23
Hydrochlorothiazide	Hydrochlorothiazide	83	30
Duloxetine Hcl	Duloxetine Hcl	81	26
Bupropion Xl	Bupropion Hcl	80	18
Citalopram Hbr	Citalopram Hydrobromide	78	21
Potassium Chloride	Potassium Chloride	76	24
Fluoxetine Hcl	Fluoxetine Hcl	69	22
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	68	25
Escitalopram Oxalate	Escitalopram Oxalate	67	17
Alendronate Sodium	Alendronate Sodium	61	25
Montelukast Sodium	Montelukast Sodium	61	13
Ozempic	Semaglutide	61	13
Tamsulosin Hcl	Tamsulosin Hcl	61	15
Warfarin Sodium	Warfarin Sodium	60	17
Clopidogrel	Clopidogrel Bisulfate	57	26
Metoprolol Tartrate	Metoprolol Tartrate	55	20
Carvedilol	Carvedilol	54	16
Atenolol	Atenolol	51	13
Baclofen	Baclofen	50	suppressed
Pregabalin	Pregabalin	50	12
Venlafaxine Hcl Er	Venlafaxine Hcl	50	suppressed
Fluticasone Propionate	Fluticasone Propionate	47	23
Pravastatin Sodium	Pravastatin Sodium	47	17
Jardiance	Empagliflozin	45	14
Tizanidine Hcl	Tizanidine Hcl	45	11
Estradiol	Estradiol	43	18
Ibuprofen	Ibuprofen	43	suppressed
Tramadol Hcl	Tramadol Hcl	43	16
Ondansetron Odt	Ondansetron	39	15
Alprazolam	Alprazolam	38	17
Lovastatin	Lovastatin	36	11
Oxycodone Hcl	Oxycodone Hcl	36	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	34	16
Buspirone Hcl	Buspirone Hcl	30	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	30	suppressed
Spironolactone	Spironolactone	30	12
Amitriptyline Hcl	Amitriptyline Hcl	28	suppressed
Divalproex Sodium	Divalproex Sodium	28	suppressed
Glipizide	Glipizide	28	suppressed
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	28	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	28	suppressed
Diclofenac Sodium	Diclofenac Sodium	27	14
Ezetimibe	Ezetimibe	27	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	26	suppressed
Donepezil Hcl	Donepezil Hcl	25	suppressed
Memantine Hcl	Memantine Hcl	25	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	25	20
Chlorthalidone	Chlorthalidone	24	suppressed
Mounjaro	Tirzepatide	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	14
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	23	suppressed
Famotidine	Famotidine	23	11
Januvia	Sitagliptin Phosphate	23	suppressed
Allopurinol	Allopurinol	22	suppressed
Topiramate	Topiramate	22	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	21	suppressed
Cephalexin	Cephalexin	20	11
Lorazepam	Lorazepam	20	13
Nifedipine Er	Nifedipine	20	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Clonazepam	Clonazepam	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Lamotrigine	Lamotrigine	17	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	17	suppressed
Prazosin Hcl	Prazosin Hcl	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Risperidone	Risperidone	16	suppressed
Torsemide	Torsemide	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Premarin	Estrogens, Conjugated	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	13
Cholestyramine Light	Cholestyramine	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	14	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Diazepam	Diazepam	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Primidone	Primidone	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Valsartan	Valsartan	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Bydureon Bcise	Exenatide Microspheres	12	suppressed
Carbamazepine Er	Carbamazepine	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Finasteride	Finasteride	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Meloxicam	Meloxicam	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Thioridazine Hcl	Thioridazine Hcl	12	suppressed
Varenicline Tartrate	Varenicline Tartrate	12	suppressed
Celecoxib	Celecoxib	11	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Methimazole	Methimazole	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Prednisone	Prednisone	11	suppressed
Promethazine Hcl	Promethazine Hcl	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error